Suchergebnisse - "Pinato, David J"

PubPharm (188)

31

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

enthalten in: Hepatology international | 2023

von Vithayathil, M. | D'Alessio, A. | Fulgenzi, C. | +32

CommentIn: Hepatol Int. 2023 Aug;17(4):827-829. - PMID 37188999

32

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer : A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von El Zarif, T. | Nassar, A. | Adib, E. | +78

33

Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma

enthalten in: JHEP reports : innovation in hepatology | 2023

von Pinato, D. | Kaneko, T. | D'Alessio, A. | +21

34

Tumor and local lymphoid tissue interaction determines prognosis in high-grade serous ovarian cancer

enthalten in: Cell reports. Medicine | 2023

von Lu, H. | Lou, H. | Wengert, G. | +14

35

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Cortellini, A. | D'Alessio, A. | Cleary, S. | +55

CommentIn: Clin Cancer Res. 2023 Oct 2;29(19):4017-4018. - PMID 37779446

36

Personalised management of patients with hepatocellular carcinoma : a multiparametric therapeutic hierarchy concept

enthalten in: The Lancet. Oncology | 2023

von Vitale, A. | Cabibbo, G. | Iavarone, M. | +55

37

Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization : a Systematic Review and Meta-analysis

enthalten in: Journal of gastrointestinal cancer | 2023

von Mishra, G. | Majeed, A. | Dev, A. | +8

38

Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma

enthalten in: JHEP reports : innovation in hepatology | 2023

von Pinato, D. | Li, X. | Mishra-Kalyani, P. | +14

39

Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Alessi, J. | Elkrief, A. | Ricciuti, B. | +25

CommentIn: J Thorac Oncol. 2023 Jun;18(6):682-685. - PMID 37210177

40

Tumor-infiltrating Neutrophils : Gatekeepers in Liver Cancer Immune Control

enthalten in: Gastroenterology | 2023

von Scheiner, B. | Pinato, D.

CommentOn: Nature. 2022 Dec;612(7938):141-147. - PMID 36352227